<VariationArchive VariationID="134130" VariationName="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs)" VariationType="Duplication" Accession="VCV000134130" Version="41" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-15" DateCreated="2014-06-09" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="137869" VariationID="134130">
      <GeneList>
        <Gene Symbol="ERCC3" FullName="ERCC excision repair 3, TFIIH core complex helicase subunit" GeneID="2071" HGNC_ID="HGNC:3435" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="127257290" stop="127294144" display_start="127257290" display_stop="127294144" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="128014865" stop="128051751" display_start="128014865" display_stop="128051751" Strand="-" />
          </Location>
          <OMIM>133510</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000122.2(ERCC3):c.1421dup (p.Asp474fs)</Name>
      <CanonicalSPDI>NC_000002.12:127280552:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="127280552" stop="127280553" display_start="127280552" display_stop="127280553" variantLength="1" positionVCF="127280552" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="128038128" stop="128038129" display_start="128038128" display_stop="128038129" variantLength="1" positionVCF="128038128" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>D474fs</ProteinChange>
      <ProteinChange>D410fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.128038129dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.128038129dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.127280553dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.127280553dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007454.1" sequenceAccession="NG_007454" sequenceVersion="1" change="g.18624dup">
            <Expression>NG_007454.1:g.18624dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000122.2" sequenceAccession="NM_000122" sequenceVersion="2" change="c.1421dup" MANESelect="true">
            <Expression>NM_000122.2:c.1421dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000113.1" sequenceAccession="NP_000113" sequenceVersion="1" change="p.Asp474fs">
            <Expression>NP_000113.1:p.Asp474fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001303416.2" sequenceAccession="NM_001303416" sequenceVersion="2" change="c.1229dup">
            <Expression>NM_001303416.2:c.1229dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001290345.1" sequenceAccession="NP_001290345" sequenceVersion="1" change="p.Asp410fs">
            <Expression>NP_001290345.1:p.Asp410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001303418.2" sequenceAccession="NM_001303418" sequenceVersion="2" change="c.1229dup">
            <Expression>NM_001303418.2:c.1229dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001290347.1" sequenceAccession="NP_001290347" sequenceVersion="1" change="p.Asp410fs">
            <Expression>NP_001290347.1:p.Asp410fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_462" sequenceAccession="LRG_462">
            <Expression>LRG_462:g.18624dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000122.1" sequenceAccession="NM_000122" sequenceVersion="1" change="c.1421dupA">
            <Expression>NM_000122.1:c.1421dupA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_462t1" sequenceAccession="LRG_462t1">
            <Expression>LRG_462t1:c.1421dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA158854" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="133510.0006" DB="OMIM" />
        <XRef Type="rs" ID="587778281" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00006" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00040" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
        <AlleleFrequency Value="0.00006" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00007" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00008" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs) AND Xeroderma pigmentosum group B" Accession="RCV000018055" Version="33">
        <ClassifiedConditionList TraitSetID="5440">
          <ClassifiedCondition DB="MedGen" ID="C0268136">Xeroderma pigmentosum group B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-10-08" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs) AND not specified" Accession="RCV000120802" Version="2">
        <ClassifiedConditionList TraitSetID="9590">
          <ClassifiedCondition DB="MedGen" ID="CN169374">not specified</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description DateLastEvaluated="2013-09-19" SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs) AND not provided" Accession="RCV000482017" Version="29">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-05-01" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs) AND Xeroderma pigmentosum" Accession="RCV002255296" Version="3">
        <ClassifiedConditionList TraitSetID="7951">
          <ClassifiedCondition DB="MedGen" ID="C0043346">Xeroderma pigmentosum</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-23" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000122.2(ERCC3):c.1421dup (p.Asp474fs) AND multiple conditions" Accession="RCV002477310" Version="2">
        <ClassifiedConditionList TraitSetID="31402">
          <ClassifiedCondition DB="MedGen" ID="C4225344">Trichothiodystrophy 2, photosensitive</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268136">Xeroderma pigmentosum group B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-02-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-01" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2014-06-09" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16947863</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29625052</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30414346</ID>
        </Citation>
        <DescriptionHistory Dated="2022-06-09">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2017-04-26">
          <Description>not provided</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="7951" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="7021" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum</ElementValue>
                <XRef ID="Xeroderma+pigmentosum/7564" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019600" DB="MONDO" />
                <XRef ID="44600005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosa</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">XP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7910" />
                <XRef ID="7910" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="910" DB="Orphanet" />
              <XRef ID="C0043346" DB="MedGen" />
              <XRef ID="MONDO:0019600" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31402" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5131" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, complementation group b</ElementValue>
                <XRef ID="Xeroderma+pigmentosum%2C+complementation+group+b/9520" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP B</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XPB/CS</ElementValue>
                <XRef ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME</ElementValue>
                <XRef Type="Allelic variant" ID="133510.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0004" DB="OMIM" />
                <XRef ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum group B</ElementValue>
                <XRef ID="MONDO:0012531" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XPB</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPBC</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5625" />
                <XRef ID="5625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268136" DB="MedGen" />
              <XRef ID="MONDO:0012531" DB="MONDO" />
              <XRef Type="MIM" ID="610651" DB="OMIM" />
            </Trait>
            <Trait ID="33411" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Trichothiodystrophy 2, photosensitive</ElementValue>
                <XRef ID="MONDO:0014615" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TTD2</ElementValue>
                <XRef Type="MIM" ID="616390" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16100" />
                <XRef ID="16100" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="33364" DB="Orphanet" />
              <XRef ID="C4225344" DB="MedGen" />
              <XRef ID="MONDO:0014615" DB="MONDO" />
              <XRef Type="MIM" ID="616390" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5440" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5131" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Xeroderma pigmentosum, complementation group b</ElementValue>
                <XRef ID="Xeroderma+pigmentosum%2C+complementation+group+b/9520" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XP, GROUP B</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XPB/CS</ElementValue>
                <XRef ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME</ElementValue>
                <XRef Type="Allelic variant" ID="133510.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="133510.0004" DB="OMIM" />
                <XRef ID="610651" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Xeroderma pigmentosum group B</ElementValue>
                <XRef ID="MONDO:0012531" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XPB</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XPBC</ElementValue>
                <XRef Type="MIM" ID="610651" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Xeroderma pigmentosum (XP) is characterized by: Acute sun sensitivity (severe sunburn with blistering, persistent erythema on minimal sun exposure) with marked freckle-like pigmentation of the face before age two years; Sunlight-induced ocular involvement (photophobia, severe keratitis, atrophy of the skin of the lids, ocular surface neoplasms); Greatly increased risk of sunlight-induced cutaneous neoplasms (basal cell carcinoma, squamous cell carcinoma, melanoma) within the first decade of life. Approximately 25% of affected individuals have neurologic manifestations (acquired microcephaly, diminished or absent deep tendon stretch reflexes, progressive sensorineural hearing loss, progressive cognitive impairment, and ataxia). The most common causes of death are skin cancer, neurologic degeneration, and internal cancer. The median age at death in persons with XP with neurodegeneration (29 years) was found to be younger than that in persons with XP without neurodegeneration (37 years).</Attribute>
                <XRef ID="NBK1397" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5625" />
                <XRef ID="5625" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301571</ID>
                <ID Source="BookShelf">NBK1397</ID>
              </Citation>
              <XRef ID="C0268136" DB="MedGen" />
              <XRef ID="MONDO:0012531" DB="MONDO" />
              <XRef Type="MIM" ID="610651" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9590" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16789" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">AllHighlyPenetrant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not specified</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not specified' was created for use in ClinVar so that submitters can convey the concept that a variant is benign, likely benign, or of uncertain significance for an unspecified set of disorders.  This usage was introduced in 2014 to replace AllHighlyPenetrant.</Attribute>
              </AttributeSet>
              <XRef ID="CN169374" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="281935" SubmissionDate="2014-05-29" DateLastUpdated="2014-06-09" DateCreated="2014-06-09">
        <ClinVarSubmissionID localKey="MedGen:CN169374" />
        <ClinVarAccession Accession="SCV000084966" DateUpdated="2014-06-09" DateCreated="2014-06-09" Type="SCV" Version="1" SubmitterName="ITMI" OrgID="504914" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-09-19">
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Whole_cohort</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>681</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.0007</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>African</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>43</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>African_European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>46</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Central_Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>50</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>East_Asian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>62</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>European</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>331</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0.0015</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Hispanic</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>118</NumberTested>
            </Sample>
            <Method>
              <NamePlatform>Complete Genomics</NamePlatform>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <MethodType>reference population</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="AlleleFrequency">0</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="T" referenceAllele="-" start="128038128" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">AllHighlyPenetrant</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="CN169374" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">24728327</ID>
        </Citation>
        <Comment Type="public">Please see associated publication for description of ethnicities</Comment>
        <SubmissionNameList>
          <SubmissionName>Cancer_genes_01</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4951393" SubmissionDate="2022-04-25" DateLastUpdated="2022-06-24" DateCreated="2022-06-24">
        <ClinVarSubmissionID localKey="NM_000122.1:c.1421dupA|MedGen:C0043346" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002532598" DateUpdated="2022-06-24" DateCreated="2022-06-24" Type="SCV" Version="1" SubmitterName="Sema4, Sema4" OrgID="500057" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16947863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29625052</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30414346</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Sema4 Curation Guidelines</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/cy0kpury/sema4_variant_curation_guidelines-clinvar_april_2022.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000122.1:c.1421dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0043346" Type="CUI" />
          </Trait>
        </TraitSet>
        <Comment>The ERCC3 c.1421dupA (p.D474EfsX2) variant has been reported in individuals with xeroderma pigmentosum and Cockayne syndrome, sarcoma, melanoma and uterine carcinoma (PMID: 16947863, 29625052, 30414346). This variant causes a frameshift at amino acid 474 that results in premature termination 2 amino acids downstream. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Loss of function of the ERCC3 gene is an established disease mechanism in xeroderma pigmentosum group B (clinicalgenome.org). It was observed in 18/129082 chromosomes of the Non-Finnish European subpopulation in the large and broad cohorts of the Genome Aggregation Database (http://gnomad.broadinstitute.org, PMID: 32461654). The variant has been reported in ClinVar (Variation ID 134130). Based on the current evidence available, this variant is interpreted as pathogenic.</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB11360768</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="38334" SubmissionDate="2015-05-29" DateLastUpdated="2022-09-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="133510.0006_XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME" title="ERCC3, 1-BP INS, 1421A_XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME" />
        <ClinVarAccession Accession="SCV000038334" DateUpdated="2022-09-24" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with a severe form of type B xeroderma pigmentosum/Cockayne syndrome (610651), Oh et al. (2006) identified compound heterozygosity for 2 mutations in the ERCC3 gene: a splice site mutation (133510.0001) and a 1-bp insertion (1421insA) in exon 9, resulting in a frameshift and premature termination of the protein at codon 475.</Attribute>
              <Citation>
                <ID Source="PubMed">16947863</ID>
              </Citation>
              <XRef DB="OMIM" ID="610651" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC3" />
          </GeneList>
          <Name>ERCC3, 1-BP INS, 1421A</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 1421A</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="133510.0006" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5427657" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000122.2:c.1421dup|OMIM:610651;616390" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002778452" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-02-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000122.2:c.1421dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610651" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="616390" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7911761" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2024-02-04">
        <ClinVarSubmissionID localKey="2515ebfd6743973e9eaa4d05e7b9e20fafeba3ba3fbd485901b6f9cf5964da3e|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004235169" DateUpdated="2024-02-04" DateCreated="2024-02-04" Type="SCV" Version="1" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000122.2:c.1421dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2467299" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2020-05-12">
        <ClinVarSubmissionID localKey="101075|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001245707" DateUpdated="2024-07-15" DateCreated="2020-05-12" Type="SCV" Version="23" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>ERCC3: PVS1, PM2:Supporting</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="2" alternateAllele="AT" referenceAllele="A" start="128038128" stop="128038128" variantLength="1" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-07</SubmissionName>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2697346" SubmissionDate="2020-11-24" DateLastUpdated="2020-12-12" DateCreated="2020-07-04">
        <ClinVarSubmissionID localKey="NM_000122.1:c.1421dupA|OMIM:610651" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001369260" DateUpdated="2020-12-12" DateCreated="2020-07-04" Type="SCV" Version="2" SubmitterName="Centre for Mendelian Genomics, University Medical Centre Ljubljana" OrgID="505952" OrganizationCategory="clinic" OrgAbbreviation="CMG-UMCL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-10-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP5.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000122.1:c.1421dupA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="610651" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8622351</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1101631" SubmissionDate="2023-11-22" DateLastUpdated="2023-11-25" DateCreated="2017-04-27">
        <ClinVarSubmissionID localKey="GDXSV:311861" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000566524" DateUpdated="2023-11-25" DateCreated="2017-04-27" Type="SCV" Version="6" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Also known as c.1421_1422insA; This variant is associated with the following publications: (PMID: 26971583, 27356891, 31589614, 30414346, 29625052, 34308104, 24728327, 36451132, 36493725, 16947863)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC3" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:409380</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000122.1:c.1421dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_111_20220608054204</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_236_20231122054204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4258876" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="3599041|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002241342" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16947863</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16947863</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp474Glufs*2) in the ERCC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC3 are known to be pathogenic (PMID: 16947863). This variant is present in population databases (rs587778281, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with xeroderma pigmentosa (PMID: 16947863). ClinVar contains an entry for this variant (Variation ID: 134130). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ERCC3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.128038128_128038129insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7911761" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="281935" TraitType="Disease" MappingType="Name" MappingValue="AllHighlyPenetrant" MappingRef="Preferred">
        <MedGen CUI="CN169374" Name="not specified" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427657" TraitType="Disease" MappingType="XRef" MappingValue="610651" MappingRef="OMIM">
        <MedGen CUI="C0268136" Name="Xeroderma pigmentosum group B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2697346" TraitType="Disease" MappingType="XRef" MappingValue="610651" MappingRef="OMIM">
        <MedGen CUI="C0268136" Name="Xeroderma pigmentosum group B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1101631" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="38334" TraitType="Disease" MappingType="Name" MappingValue="XERODERMA PIGMENTOSUM B/COCKAYNE SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0268136" Name="Xeroderma pigmentosum group B" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4258876" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4951393" TraitType="Disease" MappingType="XRef" MappingValue="C0043346" MappingRef="MedGen">
        <MedGen CUI="C0043346" Name="Xeroderma pigmentosum" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2467299" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5427657" TraitType="Disease" MappingType="XRef" MappingValue="616390" MappingRef="OMIM">
        <MedGen CUI="C4225344" Name="Trichothiodystrophy 2, photosensitive" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2021-06-21">SCV001530113</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

